{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:39:29Z","timestamp":1790073569367,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To investigate whether the ultrasound microcystic pattern (MCP) can accurately predict borderline ovarian tumors (BOTs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective collection of 393 patients who met the inclusion criteria was used as the study population. Indicators that could well identify BOT in different pathological types of tumors were derived by multivariate unordered logistic regression analysis. Finally, the correlation between ultrasound MCP and pathological features was analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>(1) MCP was present in 55 of 393 ovarian tumors, including 34 BOTs (34\/68, 50.0%), 16 malignant tumors (16\/88, 18.2%), and 5 benign tumors (5\/237, 2.1%). (2) Univariate screening showed significant differences (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) in patient age, CA-125 level, ascites,\u2009&gt;\u200910 cyst locules, a solid component, blood flow, and MCP among BOTs, benign ovarian tumors, and malignant ovarian tumors. (3) Multivariate unordered logistic regression analysis showed that the blood flow,\u2009&gt;\u200910 cyst locules, and MCP were significant factors in identifying BOTs (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). (4) The pathology of ovarian tumors with MCP showed \"bubble\"- or \"fork\"- like loose tissue structures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>MCP can be observed in different pathological types of ovarian tumors and can be used as a novel sonographic marker to differentiate between BOTs, benign tumors and malignant tumors. MCP may arise as a result of anechoic cystic fluid filling the loose tissue gap.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-023-01253-8","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T03:27:07Z","timestamp":1691724427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Can the ultrasound microcystic pattern accurately predict borderline ovarian tumors?"],"prefix":"10.1186","volume":"16","author":[{"given":"Danyi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3123-1138","authenticated-orcid":false,"given":"Guorong","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaduan","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"1253_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00428-016-2040-8","volume":"470","author":"S Hauptmann","year":"2017","unstructured":"Hauptmann S, Friedrich K, Redline R, Avril S. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria. Virchows Arch. 2017;470:125\u201342.","journal-title":"Virchows Arch"},{"key":"1253_CR2","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1097\/00000478-200209000-00002","volume":"26","author":"J Prat","year":"2002","unstructured":"Prat J, De Nictolis M. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol. 2002;26:1111\u201328.","journal-title":"Am J Surg Pathol"},{"key":"1253_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ejogrb.2009.04.031","volume":"145","author":"MS Lenhard","year":"2009","unstructured":"Lenhard MS, Mitterer S, K\u00fcmper C, et al. Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort. Eur J Obstet Gynecol Reprod Biol. 2009;145:189\u201394.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1253_CR4","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.humpath.2004.03.003","volume":"35","author":"SG Silverberg","year":"2004","unstructured":"Silverberg SG, Bell DA, Kurman RJ, et al. Borderline ovarian tumors: key points and workshop summary. Hum Pathol. 2004;35:910\u20137.","journal-title":"Hum Pathol"},{"key":"1253_CR5","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/uog.17414","volume":"50","author":"F Moro","year":"2017","unstructured":"Moro F, Baima Poma C, Zannoni GF, et al. Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors. Ultrasound Obstet Gynecol. 2017;50:788\u201399.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1253_CR6","first-page":"382","volume":"38","author":"A Pascual","year":"2017","unstructured":"Pascual A, Guerriero S, Rams N, et al. Clinical and ultrasound features of benign, borderline, and malignant invasive mucinous ovarian tumors. Eur J Gynaecol Oncol. 2017;38:382\u20136.","journal-title":"Eur J Gynaecol Oncol"},{"key":"1253_CR7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/uog.2607","volume":"26","author":"E Fruscella","year":"2005","unstructured":"Fruscella E, Testa AC, Ferrandina G, et al. Ultrasound features of different histopathological subtypes of borderline ovarian tumors. Ultrasound Obstet Gynecol. 2005;26:644\u201350.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1253_CR8","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/uog.15963","volume":"49","author":"KG Araujo","year":"2017","unstructured":"Araujo KG, Jales RM, Pereira PN, et al. Performance of the IOTA ADNEX model in preoperative discrimination of adnexal masses in a gynecological oncology center. Ultrasound Obstet Gynecol. 2017;49:778\u201383.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1253_CR9","doi-asserted-by":"publisher","first-page":"m2614","DOI":"10.1136\/bmj.m2614","volume":"370","author":"B Van Calster","year":"2020","unstructured":"Van Calster B, Valentin L, Froyman W, et al. Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study. BMJ. 2020;370:m2614.","journal-title":"BMJ"},{"key":"1253_CR10","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/uog.20363","volume":"54","author":"H Chen","year":"2019","unstructured":"Chen H, Qian L, Jiang M, Du Q, Yuan F, Feng W. Performance of IOTA ADNEX model in evaluating adnexal masses in a gynecological oncology center in China. Ultrasound Obstet Gynecol. 2019;54:815\u201322.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1253_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/uog.20283","volume":"54","author":"IE Timor-Tritsch","year":"2019","unstructured":"Timor-Tritsch IE, Foley CE, Brandon C, et al. New sonographic marker of borderline ovarian tumor: microcystic pattern of papillae and solid components. Ultrasound Obstet Gynecol. 2019;54:395\u2013402.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1253_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00330-020-07113-z","volume":"31","author":"X Zheng","year":"2021","unstructured":"Zheng X, Lyu G, Gan Y, et al. Microcystic pattern and shadowing are independent predictors of ovarian borderline tumors and cystadenofibromas in ultrasound. Eur Radiol. 2021;31:45\u201354.","journal-title":"Eur Radiol"},{"key":"1253_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1046\/j.1469-0705.2000.00287.x","volume":"16","author":"D Timmerman","year":"2000","unstructured":"Timmerman D, Valentin L, Bourne TH, Collins WP, Verrelst H, Vergote I. International Ovarian Tumor Analysis (IOTA) Group. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol. 2000;16:500\u20135.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"1253_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/RUQ.0000000000000506","volume":"37","author":"X Zheng","year":"2021","unstructured":"Zheng X, Lyu G, Shen X, Hu M. Ultrasound characteristics of Cystadenofibromas: a retrospective multicenter study. Ultrasound Q. 2021;37(4):349\u201356.","journal-title":"Ultrasound Q"},{"issue":"4","key":"1253_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/uog.9012","volume":"38","author":"F Amor","year":"2011","unstructured":"Amor F, Alc\u00e1zar JL, Vaccaro H, Le\u00f3n M, Iturra A. GI-RADS reporting system for ultrasound evaluation of adnexal masses in clinical practice: a prospective multicenter study. Ultrasound Obstet Gynecol. 2011;38(4):450\u20135.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1253_CR16","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/IGC.0000000000000282","volume":"24","author":"P Harter","year":"2014","unstructured":"Harter P, Gershenson D, Lhomme C, et al. Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors). Int J Gynecol Cancer. 2014;24:S5-8.","journal-title":"Int J Gynecol Cancer"},{"key":"1253_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/00013644-200303000-00003","volume":"19","author":"TR Alfuhaid","year":"2003","unstructured":"Alfuhaid TR, Rosen BP, Wilson SR. Low-malignant-potential tumor of the ovary: sonographic features with clinicopathologic correlation in 41 patients. Ultrasound Q. 2003;19:13\u201326.","journal-title":"Ultrasound Q"},{"key":"1253_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/jcu.10028","volume":"30","author":"MA Pascual","year":"2002","unstructured":"Pascual MA, Tresserra F, Grases PJ, Labastida R, Dexeus S. Borderline cystic tumors of the ovary: gray-scale and color Doppler sonographic findings. J Clin Ultrasound. 2002;30:76\u201382.","journal-title":"J Clin Ultrasound"},{"key":"1253_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/uog.1823","volume":"25","author":"C Exacoustos","year":"2005","unstructured":"Exacoustos C, Romanini ME, Rinaldo D, et al. Preoperative sonographic features of borderline ovarian tumors. Ultrasound Obstet Gynecol. 2005;25:50\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1253_CR20","doi-asserted-by":"publisher","first-page":"8794","DOI":"10.1200\/JCO.2005.01.7632","volume":"23","author":"D Timmerman","year":"2005","unstructured":"Timmerman D, Testa AC, Bourne T, et al. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol. 2005;23:8794\u2013801.","journal-title":"J Clin Oncol"},{"key":"1253_CR21","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ajog.2017.07.019","volume":"217","author":"JS Abramowicz","year":"2017","unstructured":"Abramowicz JS, Timmerman D. Ovarian mass-differentiating benign from malignant: the value of the International Ovarian Tumor Analysis ultrasound rules. Am J Obstet Gynecol. 2017;217:652\u201360.","journal-title":"Am J Obstet Gynecol"},{"key":"1253_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/uog.5365","volume":"31","author":"D Timmerman","year":"2008","unstructured":"Timmerman D, Testa AC, Bourne T, et al. Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol. 2008;31:681\u201390.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1253_CR23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1148\/radiol.2019191150","volume":"294","author":"RF Andreotti","year":"2020","unstructured":"Andreotti RF, Timmerman D, Strachowski LM, et al. O-RADS US risk stratification and management system: a consensus guideline from the ACR ovarian-adnexal reporting and data system committee. Radiology. 2020;294:168\u201385.","journal-title":"Radiology"},{"key":"1253_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/uog.18951","volume":"52","author":"C Landolfo","year":"2018","unstructured":"Landolfo C, Valentin L, Franchi D, et al. Differences in ultrasound features of papillations in unilocular-solid adnexal cysts: a retrospective international multicenter study. Ultrasound Obstet Gynecol. 2018;52:269\u201378.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1253_CR25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/uog.20277","volume":"54","author":"BA Virgilio","year":"2019","unstructured":"Virgilio BA, De Blasis I, Sladkevicius P, et al. Imaging of gynecological disease (16): clinical and ultrasound characteristics of serous cystadenofibromas in the adnexa. Ultrasound Obstet Gynecol. 2019;54:823\u201330.","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01253-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-023-01253-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01253-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T15:34:12Z","timestamp":1700408052000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-023-01253-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1253"],"URL":"https:\/\/doi.org\/10.1186\/s13048-023-01253-8","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"assertion":[{"value":"26 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Institutional Review Boards (IRBs) of the Second Affiliated Hospital of Fujian Medical University (IRBs No.2022519), and the requirement for written informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}